Lonza to buy U.S. biologics site from Roche for $1.2B (OTCMKTS:LZAGF)

Lonza to buy U.S. biologics site from Roche for $1.2B (OTCMKTS:LZAGF)

Swiss contract drug manufacturer Lonza (OTCPK:LZAGF) (OTCPK:LZAGY) has agreed to acquire a large-scale biologics manufacturing site in California from Roche (OTCQX:RHHBY) (OTCQX:RHHBF) for $1.2B in cash.

The Genentech facility in Vacaville is one of the largest biologics manufacturing facilities in the world by volume, with a bioreactor capacity of around 330,000 liters.

The post Lonza to buy U.S. biologics site from Roche for $1.2B (OTCMKTS:LZAGF) first appeared on Investorempires.com.

 

US Bans AI-Generated Voices Used in Scam Robocalls After Biden Impersonation Frauds | Investorempires.com

Read More | To crack down on fraudulent activities and safeguard consumer interests, the Federal Communications Commission (FCC) has officially prohibited using artificial intelligence-generated voices in unwarranted robocalls across the United States. This move follows an incident where New Hampshire residents received fabricated voice messages mimicking U.S. President Joe Biden, advising against participation in the […]